Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders

Rhea-AI Summary

Resverlogix (RVXCF) held its 2026 Annual Meeting of Shareholders in Calgary, Alberta, on June 25, 2026. Shareholders elected five directors until the next annual meeting, with support levels above 97% for each nominee.

All resolutions in the May 15, 2026 Information Circular were approved. Meeting materials are available on SEDAR+ and the Resverlogix website, and a webcast archive of the executive presentation will also be accessible online.

News Market Reaction – RVXCF

-9.81%

-9.81% Session close to close

In the Jun 26 session, RVXCF declined 9.81%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Calgary, Alberta--(Newsfile Corp. - June 25, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix", or the "Corporation") today held its Annual Meeting of Shareholders (the "Meeting") in Calgary, Alberta.

During business proceedings at the Meeting, shareholders elected Five (5) Board members until the next annual meeting. The voting results of shares represented at the Meeting for individual directors were as follows:

	Votes For	Votes Withheld	Percent For	Percent Withheld
Donald J. McCaffrey	152,172,240	4,026,590	97.42%	2.58%
Kelly McNeill	152,453,272	3,745,558	97.60%	2.40%
Siu Lun (Dicky) To	153,532,006	2,666,824	98.29%	1.71%
Kenneth Zuerblis	153,419,286	2,779,544	98.22%	1.78%
Bradley Glass	153,540,531	2,658,299	98.30%	1.70%

 

Resverlogix shareholders approved all resolutions outlined in the Notice of Meeting and Management Information Circular dated May 15, 2026 (the "Information Circular"). The Information Circular is available on SEDAR+ at www.sedarplus.ca, and on the Resverlogix website at www.resverlogix.com.

A webcast archive of the executive presentation portion of the Meeting will be available HERE.

About Resverlogix

Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease.

Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients' lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.

The Company's clinical program is focused on evaluating the lead epigenetic candidate apabetalone for the treatment of cardiovascular disease, associated comorbidities, and post COVID-19 conditions.

Resverlogix common shares trade on the Toronto Stock Exchange (TSX: RVX).

Follow us on:

• X.com: @Resverlogix_RVX
• LinkedIn: linkedin.com/company/resverlogix-corp-/

Forward-Looking Statements:

This news release may contain certain forward-looking information as defined under applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts", and other similar expressions. In particular, this news release includes forward looking information related to the potential role of apabetalone in the treatment of patients with cardiovascular disease, post COVID-19 conditions, pulmonary arterial hypertension, associated comorbidities, and other chronic diseases. Our actual results, events or developments could be materially different from those expressed or implied by these forward-looking statements. We can give no assurance that any of the events or expectations will occur or be realized. By their nature, forward-looking statements are subject to numerous assumptions and risk factors including those discussed in our Annual Information Form and most recent MD&A which are incorporated herein by reference and are available through SEDAR at www.sedarplus.ca. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For further information please contact:

Investor Relations
Email: ir@resverlogix.com
Phone: 403-254-9252

www.resverlogix.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302963

FAQ

What did Resverlogix (RVXCF) announce from the 2026 annual meeting of shareholders?

Resverlogix (RVXCF) reported that shareholders elected five directors and approved all resolutions at the 2026 annual meeting. According to Resverlogix, every director nominee received more than 97% of votes cast in favor, confirming the proposed board and meeting agenda.

Which directors were elected at the 2026 Resverlogix (RVXCF) shareholder meeting?

Shareholders elected Donald J. McCaffrey, Kelly McNeill, Siu Lun (Dicky) To, Kenneth Zuerblis, and Bradley Glass. According to Resverlogix, each director will serve until the next annual meeting, after receiving strong support levels from shares represented at the 2026 meeting.

What were the voting results for Donald J. McCaffrey at the 2026 Resverlogix (RVXCF) meeting?

Donald J. McCaffrey received 152,172,240 votes for and 4,026,590 withheld at the 2026 meeting. According to Resverlogix, this represents 97.42% of votes cast for and 2.58% withheld among shares represented at the shareholder meeting.

How strongly supported was Bradley Glass in the 2026 Resverlogix (RVXCF) director election?

Bradley Glass received 153,540,531 votes for and 2,658,299 withheld at the 2026 shareholder meeting. According to Resverlogix, this equates to 98.30% of votes for and 1.70% withheld, indicating a high level of support from voting shareholders present.

Were all resolutions approved at the 2026 Resverlogix (RVXCF) annual meeting?

Yes, all resolutions outlined in the May 15, 2026 Management Information Circular were approved. According to Resverlogix, shareholders endorsed the complete slate of proposals presented in the Notice of Meeting and Information Circular for the 2026 annual meeting.

Where can investors find the 2026 Resverlogix (RVXCF) Information Circular and meeting materials?

Investors can access the May 15, 2026 Information Circular on SEDAR+ and the Resverlogix website. According to Resverlogix, these online locations host the Notice of Meeting, Circular, and related documents for the 2026 annual shareholder meeting.

How can shareholders watch the 2026 Resverlogix (RVXCF) annual meeting presentation replay?

A webcast archive of the executive presentation portion of the 2026 meeting will be made available online. According to Resverlogix, shareholders can access this archived webcast through the company’s website via the indicated presentation link when posted.